Group 1: Industry Developments - The Ministry of Finance and the People's Bank of China have included electronic savings bonds in personal pension products to support the development of a multi-tiered pension system, which is expected to enhance investor enthusiasm and improve the quality of the personal pension system [2] - A shift in the collaboration model between banks and fund companies is observed, moving from a focus on product sales to a more service-oriented approach, emphasizing long-term customer value [4] - The Hong Kong Monetary Authority has released a financial technology promotion blueprint aimed at fostering responsible innovation and enhancing cross-border collaboration in the financial sector [12] Group 2: Market Trends - In January 2026, A-share new account openings surged to 4.9158 million, a 213% increase year-on-year, indicating a strong market interest [10] - The scale of public fund of funds (FOF) has reached a historical high of over 240 billion, driven by low interest rates and a demand for low-volatility products [11] - The semiconductor sector is highlighted as a key investment area, with fund managers noting significant growth potential in the domestic semiconductor industry over the next 3-5 years [15][16] Group 3: Regulatory Changes - The China Securities Regulatory Commission has introduced new guidelines for public fund performance benchmarks to address issues like "style drift" and ensure investor interests are prioritized [6][17] - The new regulations aim to standardize performance benchmarks and improve transparency in fund management practices [6][17] Group 4: Fund Launches - A total of 29 new public funds are set to launch in the first week of February 2026, with equity funds making up the majority [9] - The average subscription period for these new funds is approximately 12 days, indicating strong investor interest [9] Group 5: Stock Performance - In January 2026, 207 out of 307 recommended stocks by brokers saw price increases, with some stocks experiencing nearly 100% gains, reflecting a positive market outlook [14] - The Hang Seng Biotechnology Index recorded a 64.5% increase last year, marking its highest annual gain since inception [8]

Group 1 - The core viewpoint of the news highlights the significant changes in the personal pension market with the introduction of state-backed products, which is expected to enhance investor enthusiasm and improve the quality of the personal pension system [2] - The collaboration model between banks and fund companies is evolving from a focus on scale and sales to a more refined and systematic approach, emphasizing long-term customer value creation [4] - The public fund industry is entering a new phase of standardization with the introduction of performance benchmarks aimed at addressing industry issues such as "style drift" and "blind box funds" [6][19] Group 2 - The A-share market saw a remarkable increase in new account openings, with January 2026 recording 4.9158 million new accounts, a 213% year-on-year increase [11] - The scale of public fund of funds (FOF) has reached a historical high, surpassing 240 billion yuan, driven by low interest rates and a shift in investor demand towards multi-asset, low-volatility products [13] - The semiconductor sector is experiencing a strong performance, with multiple segments of the industry showing significant growth potential, driven by supply-demand dynamics and technological advancements [17][18]

Core Viewpoint - The Hang Seng Index Company announced the launch of the Hang Seng Dual Technology Index in January 2026, highlighting the strong performance of the technology and biotechnology sectors in the Hong Kong market in 2025 [1] Group 1: Index Performance - The Hang Seng Biotechnology Index rose by 64.5% last year, marking its largest annual increase since inception and reversing four years of negative returns [1] - The Hang Seng Technology Index increased by 23.5% for the second consecutive year [1] Group 2: Structural Drivers - The strong performance of the biotechnology sector is attributed to three structural drivers: aging population, rising disposable income, and the potential increase in the proportion of per capita medical expenditure to GDP [1] Group 3: Index Composition - The Hang Seng Dual Technology Index innovatively replicates the constituent stocks of the Hang Seng Technology Index and the Hang Seng Biotechnology Index, with a weight allocation of 75% to the Technology Index and 25% to the Biotechnology Index [1] - The Hang Seng Technology Index includes 30 constituent stocks across six technology themes, while the Biotechnology Index also comprises 30 stocks focused on pharmaceuticals and medical devices, resulting in a total of 58 stocks in the Dual Technology Index [2] Group 4: Future Development - The company aims to solidify its market leadership in the technology and biotechnology sectors, expand the asset management scale tracking technology-related indices, and continue to develop biotechnology indices [3] - The company plans to promote product innovation, explore more applications of artificial intelligence in business, and develop cross-market indices [3] - The company reported a 27.8% increase in the Hang Seng Index for 2025, the best annual performance since 2017, with assets under management (AUM) linked to the Hang Seng Index series reaching approximately $117.7 billion [3] Group 5: Global Market Expansion - The company's ETF products are available on 17 different exchanges globally, facilitating investment flows into the Hong Kong market from international investors [4]

Core Viewpoint - The Hang Seng Index Company announced that the technology and biotechnology sectors will perform prominently in the Hong Kong stock market in 2025, with both the Hang Seng Technology Index and the Hang Seng Biotechnology Index achieving their best annual performance since their inception. In this context, the Hang Seng Dual Technology Index will be launched in January 2026, combining the constituents of both indices into a single index to highlight these two key themes [1][3]. Group 1: Performance of Indices - The Hang Seng Technology Index recorded a 23.5% increase in 2025, marking its highest annual growth since its launch in July 2020 [3]. - The Hang Seng Biotechnology Index achieved a remarkable 64.5% increase in 2025, representing its best annual performance since its inception in December 2019 [3]. - The strong performance of these indices is driven by structural factors and improvements in fundamentals [3]. Group 2: Industry Trends - The technology sector in China is a focal point, receiving clear and long-term policy support, with "significantly improving the level of technological self-reliance" being a major goal in China's 14th Five-Year Plan (2026-2030) [6]. - Artificial intelligence (AI) has become a key area of market focus, with Chinese AI models gaining global recognition [6]. - The Hang Seng Technology Index represents 30 of the largest technology companies listed in Hong Kong, focusing on areas such as smart technology, cloud computing, digital commerce, and fintech [6]. Group 3: Biotechnology Sector - The Chinese biotechnology sector has gained significant attention due to the increasing global recognition of innovative drugs developed in China, with the total value of outbound licensing transactions for innovative drugs reaching a record high of $136 billion in 2025 [7]. - This record transaction volume indicates a significant enhancement in the global competitiveness and technical capabilities of the Chinese biotechnology industry [7]. - The Hang Seng Biotechnology Index, which tracks the performance of the largest 30 biotechnology companies listed in Hong Kong, recorded a historic 64% annual increase in 2025 and continued to rise by 9% in January 2026 [8]. Group 4: Launch of the Hang Seng Dual Technology Index - The Hang Seng Dual Technology Index, launched on January 9, 2026, combines the two themes of technology and biotechnology, with a weight allocation of 75% to the Hang Seng Technology Index and 25% to the Hang Seng Biotechnology Index [12]. - The index recorded a 36% increase in 2025, with a continued upward trend into 2026, reflecting ongoing market interest in Chinese innovation themes [12]. - As of January 30, 2026, the index had a one-year annualized volatility of 34%, lower than the 35% and 40% of the Hang Seng Technology Index and Hang Seng Biotechnology Index, respectively, indicating a balanced risk profile [12].

Core Insights - The Hang Seng Index achieved its best performance since 2017, with a year-on-year increase of 27.8% as of December 31, 2025, and the assets under management (AUM) linked to the Hang Seng Index series reached approximately $117.7 billion [1] - The Hang Seng Biotechnology Index recorded a year-on-year increase of 64.5%, marking its highest annual growth since its launch in 2025 [1] Group 1: Future Development Directions - The company aims to consolidate its market leadership in the technology and biotechnology sectors, expand the AUM tracking technology-related indices, and continue to develop the biotechnology index while supporting diversified product development [1] - There is a focus on product innovation to explore more applications of artificial intelligence in business, launching products that align with market trends and demands, and developing cross-market indices [1] - The company is committed to advancing its overseas market development to help global investors seize investment opportunities in Hong Kong and mainland China [1] Group 2: Market Trends and New Products - The company noted that the biotechnology sector has gained significant attention from the capital markets, with the biotechnology index outperforming the market and other major indices by over 60% last year [1] - Three structural drivers for the healthcare industry were identified: aging population, rising disposable income, and potential for increased healthcare spending [1] - The company launched the "Hang Seng Dual Technology Index" in January to help investors capture growth opportunities in the technology and biotechnology sectors, with 75% of the index weight allocated to the Hang Seng Technology Index and 25% to the Hang Seng Biotechnology Index [2]

Core Viewpoint - The Hang Seng Index Company has launched three new indices aimed at enhancing investment and risk management tools in the Hong Kong market [1] Group 1: New Indices - The Hang Seng Dual Technology Index combines components from the Hang Seng Technology Index and the Hang Seng Biotechnology Index at a fixed ratio, covering technology and biotechnology companies listed in Hong Kong [1] - The Hang Seng Hong Kong Stock Connect Internet Technology Index tracks Hong Kong stocks that can be traded via the Stock Connect and are primarily engaged in internet or information technology businesses [1] - The Hang Seng Hong Kong Stock Connect Non-Bank Financial Index focuses on non-bank financial stocks that can be traded via the Stock Connect [1]

Core Viewpoint - The Hang Seng Index Company announced the launch of three new indices aimed at providing diversified investment strategies and trading tools in the Hong Kong market [1] Group 1: New Indices - The Hang Seng Dual Technology Index reflects the overall performance of technology and biotechnology companies listed in Hong Kong, combining components from the Hang Seng Technology Index and the Hang Seng Biotechnology Index [1] - The Hang Seng Hong Kong Stock Connect Internet Technology Index tracks the performance of Hong Kong-listed companies primarily engaged in internet or information technology businesses that can be traded via the Stock Connect [1] - The Hang Seng Hong Kong Stock Connect Non-Bank Financial Index reflects the performance of Hong Kong-listed companies in the financial sector, excluding banks, that can be traded via the Stock Connect [1]

Core Viewpoint - The Hang Seng Index Company announced the launch of three new indices aimed at enhancing investment strategies and providing real-time performance tracking for specific sectors in the Hong Kong market [1] Group 1: New Indices Overview - The Hang Seng Dual Technology Index reflects the overall performance of technology and biotechnology companies listed in Hong Kong, combining components from the Hang Seng Technology Index and the Hang Seng Biotechnology Index [1] - The Hang Seng Hong Kong Stock Connect Internet Technology Index tracks the performance of Hong Kong-listed companies primarily engaged in internet or information technology businesses that can be traded via the Stock Connect [1] - The Hang Seng Hong Kong Stock Connect Non-Bank Financial Index reflects the performance of Hong Kong-listed companies in the financial sector, excluding banks, that are accessible through the Stock Connect [1]

Group 1 - The core announcement is the launch of three new indices by the Hang Seng Index Company, which are the Hang Seng Dual Technology Index, the Hang Seng Hong Kong Stock Connect Internet Technology Industry Index, and the Hang Seng Hong Kong Stock Connect Non-Bank Financial Index [1]